HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroaki Takaya Selected Research

Thrombocytopenia (Thrombopenia)

9/2020Effect of three or more treatments with lusutrombopag in patients with cirrhotic thrombocytopenia: A retrospective single-center study.
1/2020Effectiveness of Lusutrombopag in Patients with Mild to Moderate Thrombocytopenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiroaki Takaya Research Topics

Disease

28Liver Cirrhosis (Hepatic Cirrhosis)
10/2022 - 02/2011
28Fibrosis (Cirrhosis)
10/2022 - 08/2017
12Hepatocellular Carcinoma (Hepatoma)
01/2022 - 08/2017
8Fatty Liver
10/2022 - 11/2017
8Non-alcoholic Fatty Liver Disease
11/2021 - 02/2016
8Neoplasms (Cancer)
01/2021 - 01/2015
5Hyperammonemia
08/2022 - 12/2017
5Hepatic Encephalopathy
12/2021 - 12/2017
4Sarcopenia
08/2022 - 01/2020
4Ascites
05/2022 - 08/2017
4Alcoholic Liver Diseases (Alcoholic Liver Disease)
12/2021 - 01/2013
4Inflammation (Inflammations)
12/2021 - 01/2013
4Infections
06/2021 - 01/2018
3Alcoholic Fatty Liver
10/2022 - 06/2018
3Thrombophilia
03/2022 - 05/2019
3Liver Diseases (Liver Disease)
10/2021 - 01/2019
3Dysbiosis
06/2021 - 01/2018
3Muscle Cramp (Cramp)
12/2020 - 01/2019
3Thrombosis (Thrombus)
09/2020 - 02/2011
3Hemorrhage
09/2020 - 02/2011
3Insulin Resistance
08/2020 - 09/2019
2Atrophy
08/2022 - 12/2021
2Acute-On-Chronic Liver Failure
04/2022 - 05/2020
2Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis)
09/2021 - 07/2021
2Cognitive Dysfunction
06/2021 - 03/2020
2Body Weight (Weight, Body)
01/2021 - 08/2017
2Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2020 - 01/2019
2Thrombocytopenia (Thrombopenia)
09/2020 - 01/2020
2Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
07/2020 - 01/2017
2Hypertension (High Blood Pressure)
06/2020 - 11/2017
2Endotoxemia
03/2020 - 12/2017
2Carcinogenesis
03/2020 - 11/2017
2Chronic Hepatitis (Chronic Active Hepatitis)
01/2019 - 11/2018
2Hepatitis B
11/2018 - 08/2017
2Multiple Organ Failure (MODS)
02/2018 - 09/2017
2Varicose Veins (Varicose Vein)
01/2018 - 02/2011
2Hepatitis C
01/2018 - 08/2017
1Pancreatic Neoplasms (Pancreatic Cancer)
05/2022

Drug/Important Bio-Agent (IBA)

13EndotoxinsIBA
05/2022 - 01/2013
8Biomarkers (Surrogate Marker)IBA
04/2022 - 11/2018
8von Willebrand FactorIBA
04/2022 - 09/2017
7LipopolysaccharidesIBA
10/2022 - 08/2017
6Rifaximin (L 105)FDA Link
10/2022 - 12/2017
6CytokinesIBA
08/2022 - 01/2013
6Angiotensin II Type 1 Receptor BlockersIBA
01/2022 - 02/2016
5Amino AcidsFDA Link
10/2022 - 10/2016
4Toll-Like Receptor 4IBA
10/2022 - 06/2021
4Choline (Choline Chloride)IBA
10/2022 - 10/2016
4AntigensIBA
04/2022 - 09/2017
4Losartan (Cozaar)FDA LinkGeneric
01/2022 - 11/2017
4Aspartate Aminotransferases (Aspartate Transaminase)IBA
10/2021 - 09/2017
4DiureticsIBA
01/2021 - 08/2017
3CDAA (Randox)IBA
10/2022 - 10/2016
3TolvaptanFDA Link
05/2022 - 08/2017
3ZincIBA
03/2022 - 06/2021
3Carbon Tetrachloride (Tetrachloromethane)IBA
12/2021 - 01/2021
3Anti-Bacterial Agents (Antibiotics)IBA
12/2021 - 03/2020
3Angiotensin Receptor AntagonistsIBA
12/2021 - 08/2020
3Carrier Proteins (Binding Protein)IBA
10/2021 - 08/2020
3Hyaluronic Acid (Hyaluronan)IBA
10/2021 - 08/2020
3Tissue Inhibitor of MetalloproteinasesIBA
10/2021 - 08/2020
3AntioxidantsIBA
06/2021 - 12/2020
3CollagenIBA
10/2020 - 08/2020
3Antiviral Agents (Antivirals)IBA
08/2020 - 01/2018
3Ursodeoxycholic Acid (Urso)FDA LinkGeneric
07/2020 - 02/2016
3Glucose (Dextrose)FDA LinkGeneric
03/2020 - 11/2017
2MyostatinIBA
08/2022 - 03/2022
2EnzymesIBA
04/2022 - 06/2021
2AmmoniaIBA
03/2022 - 03/2020
2Ethanol (Ethyl Alcohol)IBA
12/2021 - 01/2021
2Branched-Chain Amino AcidsIBA
12/2021 - 09/2019
2AlbuminsIBA
10/2021 - 09/2019
2Collagen Type III (Type III Collagen)IBA
10/2021 - 08/2020
2Triglycerides (Triacylglycerol)IBA
09/2021 - 06/2020
2InterleukinsIBA
06/2021 - 09/2017
2Interleukin-8 (Interleukin 8)IBA
06/2021 - 09/2017
2lenvatinibIBA
01/2021 - 01/2021
2Carnitine (L-Carnitine)FDA LinkGeneric
12/2020 - 01/2019
2procollagen Type III-N-terminal peptide (PIIP)IBA
10/2020 - 08/2020
2lusutrombopagIBA
09/2020 - 01/2020
2Bile Acids and Salts (Bile Acids)IBA
06/2020 - 11/2017
2Insulin (Novolin)FDA Link
04/2020 - 09/2019
2Alanine Transaminase (SGPT)IBA
04/2020 - 09/2017
2Sorafenib (BAY 43-9006)FDA Link
12/2019 - 05/2019
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2019 - 05/2019
2Metalloproteases (Metalloproteinases)IBA
05/2019 - 09/2017
2ThrombospondinsIBA
05/2019 - 09/2017
2Toll-Like Receptors (Toll-Like Receptor)IBA
03/2019 - 01/2013
2Dipeptidyl-Peptidase IV InhibitorsIBA
01/2019 - 11/2017
1LubiprostoneFDA Link
10/2022
1Interleukin-6 (Interleukin 6)IBA
05/2022
1obeticholic acidIBA
01/2022

Therapy/Procedure

12Therapeutics
05/2022 - 02/2011
5Oral Administration
10/2022 - 01/2018
5Drug Therapy (Chemotherapy)
12/2020 - 01/2015
3Intraperitoneal Injections
01/2021 - 01/2019
2Liver Transplantation
06/2021 - 01/2018
1Self Expandable Metallic Stents
05/2022
1Lasers (Laser)
05/2022
1Radiofrequency Ablation
01/2022